Monthly rifampin-moxifloxacin-minocycline therapy lowers the risk for type 1 reactions in patients with Hansen disease, study shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/monthly-rifampin-moxifloxacin-minocycline-therapy-lowers-2026a1000ihx?src=rss
Author :
Publish date : 2026-06-03 15:05:00
Copyright for syndicated content belongs to the linked Source.